Correction: A Case Report on Postpartum Anti-PM/Scl–Positive Dermatomyositis

Background

Postpartum autoimmune conditions, such as dermatomyositis and systemic sclerosis, can present unique clinical challenges. The overlap syndrome characterized by anti-PM/Scl autoantibodies is particularly noteworthy due to its association with interstitial lung disease.

Data Highlights

No numerical or trial data is presented in the correction notice.

Key Findings

• The authorship correction includes the affiliation of Adnan A. M. Wahdan.
• The case report discusses postpartum-onset anti-PM/Scl-positive dermatomyositis-systemic sclerosis overlap syndrome.
• This overlap syndrome is associated with reversible interstitial lung disease.
• Postpartum periods are identified as potential windows for the emergence of autoimmune diseases.

Clinical Implications

Healthcare professionals should be aware of the potential for autoimmune diseases to emerge during the postpartum period. Accurate authorship and affiliation in published literature are essential for proper attribution and credibility.

Conclusion

The correction enhances the clarity of authorship in the context of a significant case report on autoimmune overlap syndromes. Continued research and awareness are necessary for managing these complex conditions.

Related Resources & Content

1. Zghyer, J., Omarion, A., Zghyer, L., Ayasa, Y., Al-Deek, O., and Wahdan, A. A. M., Front. Med, 2026 -- Correction: A Case Report on Postpartum Anti-PM/Scl–Positive Dermatomyositis–Systemic Sclerosis Overlap Syndrome with Reversible Interstitial Lung Disease
2. Clinical Rheumatology (Springer) — MDA5-associated juvenile dermatomyositis and interstitial lung disease from rapidly progressive to silent: a report of three cases in South African children and a review of the literature
3. Clinical Research in Cardiology — Case Study of a 63-Year-Old Woman Exhibiting Fever, Muscle Pain, and Interstitial Lung Disease
4. Clinical Rheumatology — Cardiac Manifestations in Dermatomyositis Associated with Anti-MDA5 Antibodies: A Review of Case Studies
5. Clinical Rheumatology — Interstitial Lung Disease Associated with Systemic Sclerosis: A Retrospective Cross-Sectional Analysis from Taiwan
6. ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease
7. Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease: A Systematic Review and Network Meta-Analysis
8. Frontiers | Postpartum-onset anti-PM/Scl–positive dermatomyositis–systemic sclerosis overlap syndrome with reversible interstitial lung disease: a case report
9. EULAR Use of Antirheumatic Drugs in Reproduction, Pregnancy, and Lactation Guideline Summary - Guideline Central